A Committed Team of Experts

Management And Team

CEO & Co-Founder
Dirk, co-founder of BIOMILLENIA is a senior executive of the Life Sciences industry with more than 20 years of experience in product development and commercialisation. After obtaining his Ph.D. in immunology from the University of Cologne, Germany, Dirk joined QIAGEN, a global leader in Life Sciences and Molecular Diagnostics products. He has a proven track record in building high growth profitable product portfolios, has authored numerous patents and brings experience from having internationally managed product development teams and programs.
Project Lead Biology
Eric obtained his PhD in Chemical Engineering from MIT in Cambridge, MA and then joined Dow AgroSciences in Indianapolis, IN to conduct metabolic engineering of microorganisms for small molecular production and subsequent fermentation optimization. His focus at Biomillenia is on assay development in microfluidic systems.
Project Lead Microfluidics
Guansheng studied chemistry at Zhejiang University, China. He then obtained a joint PhD from Zhejiang University, China, Eindhoven University of Technology, Netherlands and Philips Research on the topic of microfluidic platforms for cell analysis and high throughput screening. Guansheng joined Biomillenia leading the technology development on microfluidics engineering and ultrahigh-throughput screening after his Postdoc at École Supérieure de Physique et de Chimie Industrielles (ESPCI, ParisTech) in Paris, France.
Project Lead Microbiology
Alex has more than 10 years research and project management experience in microbiology. After obtaining his PhD in Microbiology at the University of Kansas Medical Center in Kansas City, USA his research projects were funded twice by the European Molecular Biology Organisation (EMBO, Heidelberg, Germany) and he has conducted microbiology research at several high impact international institutions such as at the Institut National de la Santé et de la Recherche Medicale (INSERM) at Institut National de la Recherche Agronomique (INRA) in Paris, France as well as at Johns Hopkins University in Baltimore and at University of California in Irvine, USA. He is currently attending a program at the medical school of Université Paris Diderot in Paris for a diploma to become a chief investigator for clinical trials. He leads the microbiology research and discovery activities at Biomillenia.

Advisory Board

Prof. em. Dr. Dr. Detlev H. Riesner (Chairman)


Bas van Buijtenen
Aptar Pharma, France

Andrew Griffiths, PhD
ESPCI Paris, France

Prof. Dr. Dr. h.c. Manfred T. Reetz
Max-Planck Institute, Germany

Poul B. Poulsen
Formerly Novozymes, Denmark

Philippe J. Sansonetti, PhD
Institute Pasteur, France

Christopher A. Voigt, PhD
MIT, USA


©Biomillenia 2017
Disclaimer

 

BIOMILLENIA SAS, 6 Rue Jean Calvin, IPGG building
75005 Paris, France. Tel: +33 (0)1 40 79 45 96